<?xml version="1.0" encoding="UTF-8"?>
<p>The emphasis on introduced taxa in formal phytotherapy in Latin America is due to an often lacking evidence base for native botanical drugs (
 <xref rid="B96" ref-type="bibr">Caceres Guido et al., 2015</xref>; 
 <xref rid="B454" ref-type="bibr">Valdivia-Correa et al., 2016</xref>; 
 <xref rid="B30" ref-type="bibr">Alonso-Castro et al., 2017b</xref>) and the relative good documentation of effectiveness and safety issues of herbal drugs present in the European and the US Pharmacopoeia (
 <xref rid="B291" ref-type="bibr">Lozoya and Zolla, 1984</xref>; 
 <xref rid="B96" ref-type="bibr">Caceres Guido et al., 2015</xref>; 
 <xref rid="B306" ref-type="bibr">Martins et al., 2019</xref>).
</p>
